Framing Responsibility: HIV, Biomedical Prevention, and the Performativity of the Law

Journal of Bioethical Inquiry

Volumn 9, Issue 3, 2012, Pages 327-338

  Race, Kane ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biomedical prevention; Criminalization of HIV; Performativity; Randomized control trials; Responsibility; Stigma

Indexed keywords

ARTICLE; CRIMINAL LAW; ETHICS; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LEGAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL BEHAVIOR; SOCIAL STIGMA;

COMMUNICABLE DISEASE CONTROL; CRIMINAL LAW; HIV INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIAL RESPONSIBILITY; SOCIAL STIGMA; WORLD HEALTH;

EID: 84865542279     PISSN: 11767529     EISSN: 18724353     Source Type: Journal    
DOI: 10.1007/s11673-012-9375-x     Document Type: Article

References (42)

1. Adam, B. 2011. Epistemic fault lines in biomedical and social approaches to HIV prevention. Journal of the International AIDS Society 14(Suppl. 2): 1-9.
2. Austin, J. L. 1975. How to do things with words. Cambridge: Harvard University Press.
3. Badiou, A. 2006. Being and event. London and New York: Continuum.
4. Barad, K. 2003. Posthumanist performativity: Toward an understanding of how matter comes to matter. Signs 28(3): 801-831.
5. Bernard, E. 2008. Criminal HIV transmission and exposure laws spreading around the world "like a virus." NAM: aidsmap, August 7. http://www. aidsmap. com/Criminal-HIV-transmission-and-exposure-laws-spreading-around-the-world-like-a-virus/page/1431170/.
6. Bernard, E. J. 2011. Criminal HIV transmission. http://criminalhivtransmission. blogspot. com/.
7. Braun, B., and S. Whatmore. 2010. The stuff of politics: an introduction. In Political matter: Technoscience, democracy and public life, ed. B. Braun and S. Whatmore, ix-xi. Minneapolis: University of Minnesota Press.
8. Burris, S., and E. Cameron. 2008. The case against criminalization of HIV transmission. The Journal of the American Medical Association 300(5): 578-581.
9. Butler, J. 2010. Performative agency. Journal of Cultural Economy 3(2): 147-161.
10. Callon, M. 1998. The laws of the markets. Oxford: Blackwell.
11. Callon, M. 2007. What does it mean to say that economics is performative? In Do economists make markets? On the performativity of economics, ed. D. Mackenzie, F. Muniesa, and L. Siu, 311-357. Princeton: Princeton University Press.
12. Callon, M., Y. Millo, and F. Muniesa. 2007. Market devices. Oxford: Blackwell Publishing.
13. Cochoy, F. 2010. How to build displays that sell: The politics of performativity in American grocery stores. Journal of Cultural Economy 3(2): 299-315.
14. Dagnra, A., N. Vidal, A. Mensah, et al. 2011. High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo. Journal of the International AIDS Society 14: 30. doi: 10. 1186/1758-2652-14-30.
15. Diprose, R., N. Stephenson, C. Mills, K. Race, and G. Hawkins. 2008. Governing the future: The paradigm of prudence in political technologies of risk management. Security Dialogues 39(2-3): 267-288.
16. Dodds, C. 2008. Homosexually active men's views on criminal prosecutions for HIV transmission are related to HIV prevention need. AIDS Care 20(5): 509-514.
17. Dölling, D., H. Entorf, D. Hermann, and T. Rupp. 2009. Is deterrence effective? Results of a meta-analysis of punishment. European Journal on Criminal Policy and Research 15(1-2): 201-224.
18. Foucault, M. 1985. The history of sexuality, vol. 2: The use of pleasure. Trans. R. Hurley New York: Pantheon Books.
19. Hall, L., and N. Wallace. 2011. Healthcare giant must pay $300, 000 in HIV test mix-up. The Sydney Morning Herald, May 21. http://www. smh. com. au/national/healthcare-giant-must-pay-300000-in-hiv-test-mixup-20110520-1ewra. html.
20. Haraway, D. 2011. Speculative fabulations for technoculture's generations: Taking care of unexpected culture. Australian Humanities Review, no. 50. http://www. australianhumanitiesreview. org/archive/Issue-May-2011/haraway. html.
21. Hoad, N. 2010. Three poems and a pandemic. In Political emotions: New agendas in communication, ed. J. Staiger, A. Cvetkovich, and A. Reynolds, 134-150. New York and London: Routledge.
22. Kippax, S. 2003. Sexual health interventions are unsuitable for experimental evaluation. In Effective sexual health interventions: issues in experimental evaluation, ed. J. Stephenson, J. Imrie, and C. Bonell, 17-34. Oxford: Oxford University Press.
23. Latour, B. 1993. We have never been modern. Boston: Harvard University Press.
24. Latour, B. 2005. Reassembling the social: An introduction to actor-network theory. Oxford: Oxford University Press.
25. Law, J. 2004. After method: Mess in social science research. New York: Routledge.
26. Mykhalovskiy, E., G. Betteridge, and D. McLay. 2010. HIV non-disclosure and the criminal law: Establishing policy options for Ontario. Toronto: Ontario HIV Treatment Network.
27. Nguyen, V.-K., C. Y. Ako, P. Niamba, A. Sylla, and I. Tiendrébéogo. 2007. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment. AIDS 21(Supplement 5): S31-S35.
28. Padian, N. S., A. Buvé, J. Balkus, D. Serwadda, and W. Cates Jr. 2008. Biomedical interventions to prevent HIV infection: Evidence, challenges, and way forward. The Lancet 372(9638): 585-599.
29. Patton, C. 2011. Rights language and HIV treatment. Rhetoric Society Quarterly 41(3): 1-18.
30. Persson, A., and C. Newman. 2008. Making monsters: Heterosexuality, crime and race in recent Western media coverage of HIV. Sociology of Health and Illness 30(4): 632-646.
31. Race, K. 2001. The undetectable crisis: Changing technologies of risk. Sexualities 4(2): 167-189.
32. Race, K. 2009. Pleasure consuming medicine: The queer politics of drugs. Durham: Duke University Press.
33. Race, K. 2010. Click here for HIV status: Shifting templates of sexual negotiation. Emotion, Space and Society 3(1): 7-14.
34. Rosengarten, M., and M. Michael. 2009. Rethinking the bioethical enactment of medically drugged bodies: Paradoxes of using anti-HIV drug therapy as a technology for prevention. Science as Culture 18(2): 183-199.
35. Rosengarten, M., and M. Michael. 2010. HIV pre-exposure prophylaxis and the complexities of biomedical prevention. In HIV treatment and prevention technologies in international perspective, ed. M. Davis and C. Squire, 167-183. Hampshire: Palgrave MacMillan.
36. Sedgwick, E. K. 1993. Queer performativity: Henry James's The art of the novel. GLQ: A Jouranl of Lesbian and Gay Studies 1(1): 1-16.
37. Stengers, I., and O. Ralet. 1997. Drugs: ethical choice or moral consensus. In Power and Invention: Situating science, ed. I. Stengers, 215-232. Minneapolis: Minnesota University Press.
38. UNAIDS (the Joint United Nations Programme on HIV/AIDS). 2008. Criminalization of HIV transmission. UNAIDS.
39. Vernazza, P., B. Hirschel, E. Bernasconi, and M. Flepp. 2008. Les personnes seropositives ne souffrant d'aucune autre MST et suivant un traitement antiretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses 89(5): 165-169. http://www. saez. ch/docs/saez/archiv/fr/2008/2008-05/2008-05-089. PDF.
40. Weait, M. 2007. Intimacy and responsbility: The criminalisation of HIV transmission. Oxon: Routledge-Cavendish.
41. Woolgar, S. 1991. Configuring the user: The case of usability trials. In A sociology of monsters, ed. J. Law, 58-99. London: Routledge.
42. Worth, H., C. Patton, and D. Goldstein. 2005. Reckless vectors: The infecting "other" in HIV/AIDS law. Sexuality Research and Social Policy 2(2): 3-14.